Growing incidence of chronic diseases is the factor responsible for continuous exosome isolation market research. Liquid biopsy that involves analysis of biomarkers in the bodily fluids such as saliva, urine, or blood is gaining importance in chronic disease diagnostics.
Exosomes are stable carriers of the molecular information, and ideal candidates for liquid biopsy. The researchers are exploring usage of exosomal biomarkers to monitor disease progression, detection of minimal residual disease, and treatment response.
The companies operating in exosome isolation market are working toward reviewing advances in the lipid anchors-based biosensors to isolate and detect exosomes. They are also exploring the incorporation of thermoresponsive bio-affinity interfaces for enabling temperature-modulated selective capture as well as release of the targeted exosomes.
Exosomes are the smallest-size extracellular vesicles that are released by all the cell types, with size ranging between 30 and 150 nm. Exosomes, as the major markers of liquid biopsies, are capable of diagnosis, prognosis, and therapy related to the targeted disease.
Different kinds of exosomes include integrins, tetraspannins, immunomodulatory proteins, and likewise. They contain different types of intracellular proteins, cell surface proteins, DNA, RNA, metabolites, and amino acids.
Ultracentrifugation is a broadly used as well as documented method to isolate exosomes. It is generally looked upon as the gold standard. Around 56% of exosome isolation methods make use of ultracentrifugation.
However, heterogeneity of exosomes with respect to composition, size, and cargo coupled with lack of the standardized isolation methods are likely to result in variability in the experimental outcomes and hamper the comparability in studies. These factors may restrain the exosome isolation market.
| Attribute | Detail |
|---|---|
| Market Drivers |
|
Benefits of exosomes in drug delivery include low immunogenicity and toxicity, biological barrier permeability, and stability in circulation. The applications in diagnostics, vaccine development, and therapeutics are likely to expand the exosome isolation market during the forecast period.
Growing prevalence of cancer is one of the basic factors leading to the higher demand for effective new therapeutic options for diagnosing and treating the disease. For instance, as per the WHO, the year 2020 witnessed close to 10 million cancer-related fatalities, thereby marking it as a foremost cause of deaths at the global scale.
Furthermore, as per the American Cancer Society, in 2022, close to 1,918,030 novel cases of cancer along with 609,360 of cancer fatalities were recorded. In November 2022, Cell Guidance Systems launched its Instant Exosomes and LipoQ assay products. LipoQ is a lipid quantification assay and Instant Exosomes are freeze-dried exosomes.
Need to effectively combat chronic diseases such as cancer is thus majorly contributing to exosome isolation market growth.
Exosomes, in the expanding field of extracellular vesicles (EVs) research, are being proposed as advantageous diagnostic tools, therapeutic targets, and effective delivery vehicles.
The growing inclination of healthcare personnel to proffer personalized therapy on the basis of individual disease and patient characteristics is prompting them to opt for extracellular vesicles (EVs) biomarkers with therapeutic approaches. They have been proving to be ideal for personalized medicine owing to multifunctionality and diversity offered by them.
Exosomes are amongst the innovative orientations of next-generation cancer medicine. They are reported to have cancer progression-related as well as cancer healing capacities. They develop a new-fangled platform for cancer precision and personalized medicine visionary project for coming to reality.
Rising awareness about the feasibility offered by exosomes for devising precision medicine is thus driving the exosome isolation market opportunities.
| Attribute | Detail |
|---|---|
| Leading Region | North America |
As per the latest exosome isolation industry analysis, North America dominated the exosome purification landscape in 2023 and is expected to continue with its dominance during the forecast period. This is attributed to rise in awareness amongst the population regarding healthcare and diagnostics.
Several government-funded research studies are being conducted with regards to role of drugs that use exosomes in various types of cancer including breast cancer, melanoma, pancreatic cancer, and lung cancer.
Players such as Exosome Diagnostic and Merck have collaborated with and sponsored various universities such as Michigan State University and Yale University in order to facilitate conduction of clinical trials in the U.S. These ventures are being supported by the governments and emphasis is being laid on neoplasms.
Adoption of technological advancements is another factor propagating the exosome isolation market. For instance, as per the Lab on Chip Journal publication dated July 2022, the U.S. is witnessing adoption of nanotechnology for extracellular vesicles in immune-oncology, which ranges between target-specific isolations and immunomodulation.
The key players in the exosome isolation market are involved in inorganic modes of expansion to establish a strong foothold. For instance, in November 2021, Lonza announced that it had acquired an exosome manufacturing facility based at Lexington, Massachusetts (U.S.) from Codiak BioSciences.
Thermo Fisher Scientific Inc., QIAGEN N.V., Miltenyi Biotec, Sistema-Bio, Norgen Biotek, System Biosciences, LLC, STEMCELL Technologies Canada Inc., Sigma-Aldrich, Lonza Group, Bio-Techne (Exosome Platform - Diagnostics), and others are some of the key players covered in the exosome isolation industry report.
These companies have been profiled based on parameters such as company overview, business strategies, financial overview, product portfolio, and business segments.
| Attribute | Detail |
|---|---|
| Market Size in 2023 | US$ 370.7 Mn |
| Market Forecast (Value) in 2034 | US$ 1.2 Bn |
| Growth Rate (CAGR) | 11.6% |
| Forecast Period | 2024-2034 |
| Historical Data Available for | 2020-2022 |
| Quantitative Units | US$ Mn/Bn for Value |
| Market Analysis | It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces analysis, value chain analysis, and key trend analysis. |
| Competition Landscape |
|
| Format | Electronic (PDF) + Excel |
| Market Segmentation |
|
| Regions Covered |
|
| Countries Covered |
|
| Companies Profiled |
|
| Customization Scope | Available Upon Request |
| Pricing | Available Upon Request |
It was valued at US$ 370.7 Mn in 2023
It is projected to grow at a CAGR of 11.6% from 2024 to 2034
Growing prevalence of chronic diseases and rise in demand for precision medicine
Biotechnology and pharmaceutical companies segment accounted for the largest share in 2023
North America was the dominant region in 2023
Thermo Fisher Scientific Inc., QIAGEN N.V., Miltenyi Biotec, Sistema-Bio, Norgen Biotek, System Biosciences, LLC, STEMCELL Technologies Canada Inc., Sigma-Aldrich, Lonza Group, Bio-Techne (Exosome Platform - Diagnostics), and Others
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Exosome Isolation Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution/Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Exosome Isolation Market Analysis and Forecast, 2020-2034
5. Key Insights
5.1. Pipeline Analysis
5.2. Key Product /Brand Analysis
5.3. Key Mergers & Acquisitions
5.4. COVID-19 Pandemic Impact on Industry
6. Global Exosome Isolation Market Analysis and Forecast, by Technique
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Technique, 2020-2034
6.3.1. Ultracentrifugation
6.3.2. Size-exclusion Chromatography
6.3.3. Polymer-based Precipitation
6.3.4. Immunoaffinity Capture
6.3.5. Microfluids
6.3.6. Exosome Precipitation Kits
6.3.7. Others
6.4. Market Attractiveness Analysis, by Technique
7. Global Exosome Isolation Market Analysis and Forecast, by Application
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Application, 2020-2034
7.3.1. Research Applications
7.3.2. Diagnostic Applications
7.3.3. Therapeutic Applications
7.3.4. Others
7.4. Market Attractiveness Analysis, by Application
8. Global Exosome Isolation Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Market Value Forecast, by End-user, 2020-2034
8.3.1. Academic and Research Institutions
8.3.2. Biotechnology and Pharmaceutical Companies
8.3.3. Hospitals and Diagnostic Laboratories
8.3.4. Others
8.4. Market Attractiveness Analysis, by End-user
9. Global Exosome Isolation Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region, 2020-2034
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region
10. North America Exosome Isolation Market Analysis and Forecast
10.1. Introduction
10.2. Key Findings
10.3. Market Value Forecast, by Technique, 2020-2034
10.3.1. Ultracentrifugation
10.3.2. Size-exclusion Chromatography
10.3.3. Polymer-based Precipitation
10.3.4. Immunoaffinity Capture
10.3.5. Microfluids
10.3.6. Exosome Precipitation Kits
10.3.7. Others
10.4. Market Value Forecast, by Application, 2020-2034
10.4.1. Research Applications
10.4.2. Diagnostic Applications
10.4.3. Therapeutic Applications
10.4.4. Others
10.5. Market Value Forecast, by End-user, 2020-2034
10.5.1. Academic and Research Institutions
10.5.2. Biotechnology and Pharmaceutical Companies
10.5.3. Hospitals and Diagnostic Laboratories
10.5.4. Others
10.6. Market Value Forecast, by Country, 2020-2034
10.6.1. U.S.
10.6.2. Canada
10.7. Market Attractiveness Analysis
10.7.1. By Technique
10.7.2. By Application
10.7.3. By End-user
10.7.4. By Country
11. Europe Exosome Isolation Market Analysis and Forecast
11.1. Introduction
11.2. Key Findings
11.3. Market Value Forecast, by Technique, 2020-2034
11.3.1. Ultracentrifugation
11.3.2. Size-exclusion Chromatography
11.3.3. Polymer-based Precipitation
11.3.4. Immunoaffinity Capture
11.3.5. Microfluids
11.3.6. Exosome Precipitation Kits
11.3.7. Others
11.4. Market Value Forecast, by Application, 2020-2034
11.4.1. Research Applications
11.4.2. Diagnostic Applications
11.4.3. Therapeutic Applications
11.4.4. Others
11.5. Market Value Forecast, by End-user, 2020-2034
11.5.1. Academic and Research Institutions
11.5.2. Biotechnology and Pharmaceutical Companies
11.5.3. Hospitals and Diagnostic Laboratories
11.5.4. Others
11.6. Market Value Forecast, by Country/Sub-region, 2020-2034
11.6.1. Germany
11.6.2. U.K.
11.6.3. France
11.6.4. Italy
11.6.5. Spain
11.6.6. Rest of Europe
11.7. Market Attractiveness Analysis
11.7.1. By Technique
11.7.2. By Application
11.7.3. By End-user
11.7.4. By Country/Sub-region
12. Asia Pacific Exosome Isolation Market Analysis and Forecast
12.1. Introduction
12.2. Key Findings
12.3. Market Value Forecast, by Technique, 2020-2034
12.3.1. Ultracentrifugation
12.3.2. Size-exclusion Chromatography
12.3.3. Polymer-based Precipitation
12.3.4. Immunoaffinity Capture
12.3.5. Microfluids
12.3.6. Exosome Precipitation Kits
12.3.7. Others
12.4. Market Value Forecast, by Application, 2020-2034
12.4.1. Research Applications
12.4.2. Diagnostic Applications
12.4.3. Therapeutic Applications
12.4.4. Others
12.5. Market Value Forecast, by End-user, 2020-2034
12.5.1. Academic and Research Institutions
12.5.2. Biotechnology and Pharmaceutical Companies
12.5.3. Hospitals and Diagnostic Laboratories
12.5.4. Others
12.6. Market Value Forecast, by Country/Sub-region, 2020-2034
12.6.1. China
12.6.2. Japan
12.6.3. India
12.6.4. Australia & New Zealand
12.6.5. Rest of Asia Pacific
12.7. Market Attractiveness Analysis
12.7.1. By Technique
12.7.2. By Application
12.7.3. By End-user
12.7.4. By Country/Sub-region
13. Latin America Exosome Isolation Market Analysis and Forecast
13.1. Introduction
13.2. Key Findings
13.3. Market Value Forecast, by Technique, 2020-2034
13.3.1. Ultracentrifugation
13.3.2. Size-exclusion Chromatography
13.3.3. Polymer-based Precipitation
13.3.4. Immunoaffinity Capture
13.3.5. Microfluids
13.3.6. Exosome Precipitation Kits
13.3.7. Others
13.4. Market Value Forecast, by Application, 2020-2034
13.4.1. Research Applications
13.4.2. Diagnostic Applications
13.4.3. Therapeutic Applications
13.4.4. Others
13.5. Market Value Forecast, by End-user, 2020-2034
13.5.1. Academic and Research Institutions
13.5.2. Biotechnology and Pharmaceutical Companies
13.5.3. Hospitals and Diagnostic Laboratories
13.5.4. Others
13.6. Market Value Forecast, by Country/Sub-region, 2020-2034
13.6.1. Brazil
13.6.2. Mexico
13.6.3. Rest of Latin America
13.7. Market Attractiveness Analysis
13.7.1. By Technique
13.7.2. By Application
13.7.3. By End-user
13.7.4. By Country/Sub-region
14. Middle East & Africa Exosome Isolation Market Analysis and Forecast
14.1. Introduction
14.2. Key Findings
14.3. Market Value Forecast, by Technique, 2020-2034
14.3.1. Ultracentrifugation
14.3.2. Size-exclusion Chromatography
14.3.3. Polymer-based Precipitation
14.3.4. Immunoaffinity Capture
14.3.5. Microfluids
14.3.6. Exosome Precipitation Kits
14.3.7. Others
14.4. Market Value Forecast, by Application, 2020-2034
14.4.1. Research Applications
14.4.2. Diagnostic Applications
14.4.3. Therapeutic Applications
14.4.4. Others
14.5. Market Value Forecast, by End-user, 2020-2034
14.5.1. Academic and Research Institutions
14.5.2. Biotechnology and Pharmaceutical Companies
14.5.3. Hospitals and Diagnostic Laboratories
14.5.4. Others
14.6. Market Value Forecast, by Country/Sub-region, 2020-2034
14.6.1. GCC Countries
14.6.2. South Africa
14.6.3. Rest of Middle East & Africa
14.7. Market Attractiveness Analysis
14.7.1. By Technique
14.7.2. By Application
14.7.3. By End-user
14.7.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player - Competitive Matrix (by Tier and Size of Companies)
15.2. Market Share Analysis, by Company (2023)
15.3. Company Profiles
15.3.1. Thermo Fisher Scientific Inc.
15.3.1.1. Company Overview
15.3.1.2. Product Portfolio
15.3.1.3. SWOT Analysis
15.3.1.4. Financial Overview
15.3.1.5. Strategic Overview
15.3.2. QIAGEN N.V.
15.3.2.1. Company Overview
15.3.2.2. Product Portfolio
15.3.2.3. SWOT Analysis
15.3.2.4. Financial Overview
15.3.2.5. Strategic Overview
15.3.3. Miltenyi Biotec
15.3.3.1. Company Overview
15.3.3.2. Product Portfolio
15.3.3.3. SWOT Analysis
15.3.3.4. Financial Overview
15.3.3.5. Strategic Overview
15.3.4. Sistema-Bio
15.3.4.1. Company Overview
15.3.4.2. Product Portfolio
15.3.4.3. SWOT Analysis
15.3.4.4. Financial Overview
15.3.4.5. Strategic Overview
15.3.5. Norgen Biotek
15.3.5.1. Company Overview
15.3.5.2. Product Portfolio
15.3.5.3. SWOT Analysis
15.3.5.4. Financial Overview
15.3.5.5. Strategic Overview
15.3.6. System Biosciences, LLC
15.3.6.1. Company Overview
15.3.6.2. Product Portfolio
15.3.6.3. SWOT Analysis
15.3.6.4. Financial Overview
15.3.6.5. Strategic Overview
15.3.7. STEMCELL Technologies Canada Inc.
15.3.7.1. Company Overview
15.3.7.2. Product Portfolio
15.3.7.3. SWOT Analysis
15.3.7.4. Financial Overview
15.3.7.5. Strategic Overview
15.3.8. Sigma-Aldrich
15.3.8.1. Company Overview
15.3.8.2. Product Portfolio
15.3.8.3. SWOT Analysis
15.3.8.4. Financial Overview
15.3.8.5. Strategic Overview
15.3.9. Lonza Group
15.3.9.1. Company Overview
15.3.9.2. Product Portfolio
15.3.9.3. SWOT Analysis
15.3.9.4. Financial Overview
15.3.9.5. Strategic Overview
15.3.10. Bio-Techne (Exosome Platform - Diagnostics)
15.3.10.1. Company Overview
15.3.10.2. Product Portfolio
15.3.10.3. SWOT Analysis
15.3.10.4. Financial Overview
15.3.10.5. Strategic Overview
15.3.11. Others
15.3.11.1. Company Overview
15.3.11.2. Product Portfolio
15.3.11.3. SWOT Analysis
15.3.11.4. Financial Overview
15.3.11.5. Strategic Overview
List of Tables
Table 01: Global Exosome Isolation Market Size (US$ Mn) Forecast, by Technique, 2020-2034
Table 02: Global Exosome Isolation Market Size (US$ Mn) Forecast, by Application, 2020-2034
Table 03: Global Exosome Isolation Market Size (US$ Mn) Forecast, by End-user, 2020-2034
Table 04: Global Exosome Isolation Market Size (US$ Mn) Forecast, by Region, 2020-2034
Table 05: North America Exosome Isolation Market Size (US$ Mn) Forecast, by Country, 2020-2034
Table 06: North America Exosome Isolation Market Size (US$ Mn) Forecast, by Technique, 2020-2034
Table 07: North America Exosome Isolation Market Size (US$ Mn) Forecast, by Application, 2020-2034
Table 08: North America Exosome Isolation Market Size (US$ Mn) Forecast, by End-user, 2020-2034
Table 09: Europe Exosome Isolation Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
Table 10: Europe Exosome Isolation Market Size (US$ Mn) Forecast, by Technique, 2020-2034
Table 11: Europe Exosome Isolation Market Size (US$ Mn) Forecast, by Application, 2020-2034
Table 12: Europe Exosome Isolation Market Size (US$ Mn) Forecast, by End-user, 2020-2034
Table 13: Asia Pacific Exosome Isolation Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
Table 14: Asia Pacific Exosome Isolation Market Size (US$ Mn) Forecast, by Technique, 2020-2034
Table 15: Asia Pacific Exosome Isolation Market Size (US$ Mn) Forecast, by Application, 2020-2034
Table 16: Asia Pacific Exosome Isolation Market Size (US$ Mn) Forecast, by End-user, 2020-2034
Table 17: Latin America Exosome Isolation Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
Table 18: Latin America Exosome Isolation Market Size (US$ Mn) Forecast, by Technique, 2020-2034
Table 19: Latin America Exosome Isolation Market Size (US$ Mn) Forecast, by Application, 2020-2034
Table 20: Latin America Exosome Isolation Market Size (US$ Mn) Forecast, by End-user, 2020-2034
Table 21: Middle East & Africa Exosome Isolation Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
Table 22: Middle East & Africa Exosome Isolation Market Size (US$ Mn) Forecast, by Technique, 2020-2034
Table 23: Middle East & Africa Exosome Isolation Market Size (US$ Mn) Forecast, by Application, 2020-2034
Table 24: Middle East & Africa Exosome Isolation Market Size (US$ Mn) Forecast, by End-user, 2020-2034
List of Figures
Figure 01: Global Exosome Isolation Market Size (US$ Mn) and Distribution (%), by Region, 2023 and 2034
Figure 02: Global Exosome Isolation Market Revenue (US$ Mn), by Technique, 2023
Figure 03: Global Exosome Isolation Market Value Share, by Technique, 2023
Figure 04: Global Exosome Isolation Market Revenue (US$ Mn), by Application, 2023
Figure 05: Global Exosome Isolation Market Value Share, by Application, 2023
Figure 06: Global Exosome Isolation Market Revenue (US$ Mn), by End-user, 2023
Figure 07: Global Exosome Isolation Market Value Share, by End-user, 2023
Figure 08: Global Exosome Isolation Market Value Share, by Region, 2023
Figure 09: Global Exosome Isolation Market Value (US$ Mn) Forecast, 2020-2034
Figure 10: Global Exosome Isolation Market Value Share Analysis, by Technique, 2023 and 2034
Figure 11: Global Exosome Isolation Market Attractiveness Analysis, by Region, 2024-2034
Figure 12: Global Exosome Isolation Market Value Share Analysis, by Application, 2023 and 2034
Figure 13: Global Exosome Isolation Market Attractiveness Analysis, by Application, 2024-2034
Figure 14: Global Exosome Isolation Market Value Share Analysis, by End-user, 2023 and 2034
Figure 15: Global Exosome Isolation Market Attractiveness Analysis, by End-user, 2024-2034
Figure 16: Global Exosome Isolation Market Value Share Analysis, by Region, 2023 and 2034
Figure 17: Global Exosome Isolation Market Attractiveness Analysis, by Region, 2024-2034
Figure 18: North America Exosome Isolation Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 19: North America Exosome Isolation Market Attractiveness Analysis, by Country, 2024-2034
Figure 20: North America Exosome Isolation Market Value Share Analysis, by Country, 2023 and 2034
Figure 21: North America Exosome Isolation Market Value Share Analysis, by Technique, 2023 and 2034
Figure 22: North America Exosome Isolation Market Value Share Analysis, by Application, 2023 and 2034
Figure 23: North America Exosome Isolation Market Value Share Analysis, by End-user, 2023 and 2034
Figure 24: North America Exosome Isolation Market Attractiveness Analysis, by Region, 2024-2034
Figure 25: North America Exosome Isolation Market Attractiveness Analysis, by Application, 2024-2034
Figure 26: North America Exosome Isolation Market Attractiveness Analysis, by End-user, 2024-2034
Figure 27: Europe Exosome Isolation Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 28: Europe Exosome Isolation Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
Figure 29: Europe Exosome Isolation Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 30: Europe Exosome Isolation Market Value Share Analysis, by Technique, 2023 and 2034
Figure 31: Europe Exosome Isolation Market Value Share Analysis, by Application, 2023 and 2034
Figure 32: Europe Exosome Isolation Market Value Share Analysis, by End-user, 2023 and 2034
Figure 33: Europe Exosome Isolation Market Attractiveness Analysis, by Region, 2024-2034
Figure 34: Europe Exosome Isolation Market Attractiveness Analysis, by Application, 2024-2034
Figure 35: Europe Exosome Isolation Market Attractiveness Analysis, by End-user, 2024-2034
Figure 36: Asia Pacific Exosome Isolation Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 37: Asia Pacific Exosome Isolation Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
Figure 38: Asia Pacific Exosome Isolation Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 39: Asia Pacific Exosome Isolation Market Value Share Analysis, by Technique, 2023 and 2034
Figure 40: Asia Pacific Exosome Isolation Market Value Share Analysis, by Application, 2023 and 2034
Figure 41: Asia Pacific Exosome Isolation Market Value Share Analysis, by End-user, 2023 and 2034
Figure 42: Asia Pacific Exosome Isolation Market Attractiveness Analysis, by Region, 2024-2034
Figure 43: Asia Pacific Exosome Isolation Market Attractiveness Analysis, by Application, 2024-2034
Figure 44: Asia Pacific Exosome Isolation Market Attractiveness Analysis, by End-user, 2024-2034
Figure 45: Latin America Exosome Isolation Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 46: Latin America Exosome Isolation Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
Figure 47: Latin America Exosome Isolation Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 48: Latin America Exosome Isolation Market Value Share Analysis, by Technique, 2023 and 2034
Figure 49: Latin America Exosome Isolation Market Value Share Analysis, by Application, 2023 and 2034
Figure 50: Latin America Exosome Isolation Market Value Share Analysis, by End-user, 2023 and 2034
Figure 51: Latin America Exosome Isolation Market Attractiveness Analysis, by Region, 2024-2034
Figure 52: Latin America Exosome Isolation Market Attractiveness Analysis, by Application, 2024-2034
Figure 53: Latin America Exosome Isolation Market Attractiveness Analysis, by End-user, 2024-2034
Figure 54: Middle East & Africa Exosome Isolation Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 55: Middle East & Africa Exosome Isolation Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
Figure 56: Middle East & Africa Exosome Isolation Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 57: Middle East & Africa Exosome Isolation Market Value Share Analysis, by Technique, 2023 and 2034
Figure 58: Middle East & Africa Exosome Isolation Market Value Share Analysis, by Application, 2023 and 2034
Figure 59: Middle East & Africa Exosome Isolation Market Value Share Analysis, by End-user, 2023 and 2034
Figure 60: Middle East & Africa Exosome Isolation Market Attractiveness Analysis, by Region, 2024-2034
Figure 61: Middle East & Africa Exosome Isolation Market Attractiveness Analysis, by Application, 2024-2034
Figure 62: Middle East & Africa Exosome Isolation Market Attractiveness Analysis, by End-user, 2024-2034
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Exosome Isolation Market
